The Microarray and Genomic Analysis (MGA) Shared Resource provides members of the Cancer Center access to the Affymetrix and Agilent Technologies microarray platforms and to an lllumina Genome Analyzer, which enables massively parallel DNA sequencing. The Resource is operated as a full-service facility that provides expertise in experimental and computational handling of all aspects of these technologies. Services available through the Resource include evaluation of nucleic acid sample quality;labeling of samples with modified nucleotides (cy dyes or biotin);microarray hybridization;microarray scanning;feature extraction and annotation of scanned images;lllumina sequencing library preparation;lllumina cluster generation;and sequencing of prepared libraries on an lllumina Genome Analyzer. MGA bioinformatics staff members are available to support data analysis and interpretation. The technologies offered through the MGA Shared Resource support Cancer Center investigations with a diverse set of tools to measure gene, exon, or miRNA expression;SNP and DNA copy number profiling; location analysis of DNA binding proteins;DNA methylation status;and the sequencing of genomic DNA or resequencing of targeted regions of DNA. The MGA Shared Resource serves Cancer Center members from the laboratory-based scientific Programs Nuclear Control of Cell Growth and Differentiation;Cell Response and Regulation;Imaging, Diagnostics, and Therapeutics;and Gastrointestinal Cancers. Brian Dalley, PhD, joined the MGA Shared Resource at its inception in 1997. He has directed the facility since 2000 and is responsible for daily management, productivity, development, and implementation of technological improvements to the microarray and lllumina sequencing services. He has also been closely involved in the design and implementation of software for tracking microarray data. He is experienced and familiar with all aspects of the microarray and lllumina sequencing processes. The MGA Shared Resource is a Cancer Center-managed facility with supervision from HCI Directors. There is a Faculty Advisory Committee;a survey assesses user satisfaction. In 2008, usage of the MGA Shared Resource by Cancer Center members with peer-reviewed funding or other Cancer Center Shared Resources averaged 68 percent. Funds are requested from the CCSG budget to cover 6 percent ($49,745) of the proposed MGA Shared Resource budget. This Resource has ample capacity for additional use by Cancer Center members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-25
Application #
8661133
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
25
Fiscal Year
2014
Total Cost
$44,931
Indirect Cost
$19,955
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Khorashad, J S; Tantravahi, S K; Yan, D et al. (2016) Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy. Leukemia 30:2275-2279
Flores, Kristina G; Steffen, Laurie E; McLouth, Christopher J et al. (2016) Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns :
Neklason, Deborah W; VanDerslice, James; Curtin, Karen et al. (2016) Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer 23:93-100
(2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet 53:800-811
Norton, Maria C; Fauth, Elizabeth; Clark, Christine J et al. (2016) Family member deaths across adulthood predict Alzheimer's disease risk: The Cache County Study. Int J Geriatr Psychiatry 31:256-63
Piccolo, Stephen R; Hoffman, Laura M; Conner, Thomas et al. (2016) Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility. Mol Syst Biol 12:860
Zhu, Judy; Fleming, Aaron M; Orendt, Anita M et al. (2016) pH-Dependent Equilibrium between 5-Guanidinohydantoin and Iminoallantoin Affects Nucleotide Insertion Opposite the DNA Lesion. J Org Chem 81:351-9
Riedl, Jan; Fleming, Aaron M; Burrows, Cynthia J (2016) Sequencing of DNA Lesions Facilitated by Site-Specific Excision via Base Excision Repair DNA Glycosylases Yielding Ligatable Gaps. J Am Chem Soc 138:491-4
Serpico, Victoria; Liepert, Amy E; Boucher, Kenneth et al. (2016) The Effect of Previsit Education in Breast Cancer Patients: A Study of a Shared-decision-making Tool. Am Surg 82:259-65
Camp, Nicola J; Lin, Wei-Yu; Bigelow, Alex et al. (2016) Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res 76:1916-25

Showing the most recent 10 out of 1049 publications